Antibody to cloned HSV glycoproteins B and D plus adult human leukocytes protect neonatal mice from lethal HSV infection
- 1 December 1988
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 10 (6), 279-287
- https://doi.org/10.1016/0166-3542(88)90046-0
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Herpes simplex virus glycoprotein treatment of recurrent genital herpes reduces cervicovaginal virus shedding in guinea pigsAntiviral Research, 1988
- Herpes Simplex Virus Glycoprotein Treatment of Recurrent Genital HerpesThe Journal of Infectious Diseases, 1988
- Vaccination with Recombinant Herpes Simplex Virus Glycoproteins: Protection Against Initial and Recurrent Genital HerpesThe Journal of Infectious Diseases, 1987
- In Vitro and in Vivo Antibody-Dependent Cellular Cytotoxicity of Intravenous Immunoglobulin G Preparations Against Herpes Simplex VirusClinical Infectious Diseases, 1986
- Acute and latent herpes simplex virus neurological disease in mice immunized with purified virus‐specific glycoproteins gB or gDJournal of Medical Virology, 1985
- Protection from Genital Herpes Simplex Virus Type 2 Infection by Vaccination with Cloned Type 1 Glycoprotein DScience, 1985
- IgG-Mediated Viral Clearance in Experimental Infection with Herpes Simplex Virus Type 1: Role for Neutralization and Fe-Dependent Functions but not C' Cytolysis and C5 ChemotaxisThe Journal of Infectious Diseases, 1985
- Neonatal herpes simplex virus infection in King County, Washington. Increasing incidence and epidemiologic correlatesJAMA, 1983
- Immune destruction of virus-infected cells early in the infectious cycleNature, 1976
- Postexposure serum prophylaxis of neonatal herpes simplex virus infection of miceNature, 1976